Filing Details
- Accession Number:
- 0001209191-12-019351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-21 16:04:10
- Reporting Period:
- 2012-03-19
- Filing Date:
- 2012-03-21
- Accepted Time:
- 2012-03-21 16:04:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 786947 | Acura Pharmaceuticals Inc | ACUR | Pharmaceutical Preparations (2834) | 110853640 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1056695 | A Peter Clemens | C/O Acura Pharmaceuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067 | Senior Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-03-12 | 10,000 | $3.86 | 378,090 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,605 | Indirect | by son |
Footnotes
- Amount of securities include 235,000 Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in two equal installments on January 1st of each of 2013 and 2014.
- This filing shall not be deemed an admission that the reporting person is the beneficial owner of these equity securities.
Billionaire Hedge Funds
